The Effect of Glyceryl Trinitate and Diamox on Cerebral Haemodynamics.
Recruitment status was: Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention |
|---|---|
| Migraine | Drug: GTN, Diamox |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double-Blind Primary Purpose: Educational/Counseling/Training |
| Official Title: | The Effect of Glyceryl Trinitrate (GTN) and Diamox on Cerebral Haemodynamics Judged With the Help of 3-Tesla MRI. |
| Estimated Enrollment: | 12 |
| Study Start Date: | August 2006 |
| Estimated Study Completion Date: | May 2007 |
Experimental headache model open a unike opportunity to study the pathophysiological mechanisms behind headache in general and migrane in particular. Previous studies have used various techniques to study the cerebral haemodynamics as a basis for the headache pathophysiology. We wish to use a 3-Tesa MRI so study the cerebral haemodynamics after application of various pharmacological substances.
The most used experimental headache model is the glyceryl trinitrate model (GTN). Where infusion of the NO donor GTN induces headache and changes in the cerebral arteries. On the other hand injection of Diamox (Acetazolamide) apparently causes increase of the cerebral blod flow with out dilation of the arteries. We wish to study the precise effect of GTN and diamox on the cerebral haemodynamics such as Cerebral blod flow (CBF) and Cerebral blod volume (CBV) via a 3-Tesla MRI.
Eligibility| Ages Eligible for Study: | 18 Years to 55 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- healthy volunteers; men and women age 18-50 years.
- weight 50-100 kg
Exclusion Criteria:
- Tension type headache more then once per month during the last year.
- Other primary headache types.
- Daily use of medication.
- Pregnant or lactating women.
- Headache on the trail day or 24 hours prior to the trial.
- Contraindications to MRI.
- Hypotension og hypertension.
- Other significant medical conditions judged by the doctor in charge.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00363571
| Contact: Mohammad Sohail Asghar, MD | +4543232161 | asgsoh01@glostruphosp.kbhamt.dk |
| Denmark | |
| Danish Headache Center, Neurological Dep. Glostrup hospital | |
| Glostrup, Denmark, 2770 | |
| Study Chair: | Messoud Ashina, MD,Ph.D | Danish Headache Center |
More Information
| ClinicalTrials.gov Identifier: | NCT00363571 History of Changes |
| Other Study ID Numbers: |
KA-20060084 |
| Study First Received: | August 14, 2006 |
| Last Updated: | August 14, 2006 |
Additional relevant MeSH terms:
|
Acetazolamide Anticonvulsants Carbonic Anhydrase Inhibitors Enzyme Inhibitors |
Molecular Mechanisms of Pharmacological Action Diuretics Natriuretic Agents Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on July 18, 2017


IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
